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OBJECTIVES The aim of this study was to accurately assess the radiation exposure received by patients
during cardiac catheterization in a large sample representative of the current state of practice
in cardiac angiography.
BACKGROUND Radiation exposure to patients and laboratory staff has been recognized as a necessary hazard
in coronary angiography. The effects on x-ray exposure of the increased complexity of
coronary angiographic procedures and, in particular, the increasing use of coronary artery
stenting, have not been adequately addressed in previous studies.
METHODS X-ray exposure measurements were performed on a consecutive series of 972 patients
undergoing 992 diagnostic and interventional studies in the Mayo Clinic catheterization
laboratory within an eight week period in late 1997. Data were acquired from 706 diagnostic
procedures and 286 interventional procedures using a real-time exposure measurement system
to continuously calculate and record the exposure rate and total exposure, reflecting all
parameters relevant to the specific patient and procedure situation.
RESULTS The median exposure for all 992 procedures was 41.8 mC/kg (162.1 R); the corresponding
values for diagnostic and interventional procedures were 34.9 and 95.6 mC/kg, respectively
(135.3 vs. 370.5 R). There were significant differences in the fluoroscopy exposure time
between diagnostic and interventional procedures: 4.7 min vs. 21.0 min. Heavier patients
(.83 kg) received x-ray exposures at a significantly higher rate than did lighter patients
(,83 kg) during both fluoroscopy and cine; 44.9 mC/kg/min (173.9 R/min) vs. 27.9
mC/kg/min (108.3 R/min) for cine exposure rate and 2.3 mC/kg/min (8.8 R/min) vs. 1.5
mC/kg/min (5.8 R/min) for fluoroscopy exposure rate.
CONCLUSIONS Changes in practice have led to higher values for patient x-ray radiation exposures during
cardiac catheterization procedures. The real-time display and recording of x-ray exposure
facilitates the reduction of exposure in the catheterization laboratory. (J Am Coll Cardiol
1999;33:427–35) © 1999 by the American College of Cardiology
Diagnostic coronary angiography and percutaneous coro-
nary interventions are being performed in increasing num-
bers. Treatment of multivessel disease, intervention on
increasingly complex stenoses and repeat procedures neces-
sitated by restenosis have all led to a significant increase in
the amount of fluoroscopic guidance required with an
accompanying increase in radiation exposure. Radiation
exposure to the attending physician and other personnel are
recognized as potential occupational hazards (1–3); al-
though monitoring of the exposure over time to catheter-
ization laboratory personnel is mandatory, there has been no
universal attempt to monitor radiation doses received by the
patient. Despite numerous studies (4–13), there remains
some uncertainty as to what radiation risks these patients are
exposed, but skin reactions after coronary angioplasty have
been reported (14–16).
Measurements of radiation dose delivered to patients
during coronary angiography and interventional procedures
such as percutaneous transluminal coronary angioplasty
(PTCA) have been reported previously (6,10–13,17–20),
with the highest radiation doses documented with PTCA,
particularly multivessel procedures and complex procedures
(17–20). However, in few of these studies was radiation
dose to the patient measured directly (or indirectly) while
the procedure was being performed (6,12–13,17,18). There
are few data available describing radiation exposure in the
current era of widespread use of new interventional devices
(17,21), particularly stents which are now used in 40 to 70%
of all interventional cases. Implementation of ionization
chamber dosimeters or thermoluminescent detectors
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(TLD’s) for the routine monitoring of radiation exposure to
patients has not been practical. Such techniques are also
difficult to implement in an “on-line” manner, i.e., in such a
way that operators can be aware of the radiation exposure to
the patient as the procedure is being performed. Recently,
an on-line radiation dose measurement system has been
developed which can be used to provide real-time measure-
ments of radiation exposure to the patient in the catheter-
ization laboratory. The measurement system can be net-
worked throughout a catheterization laboratory and stores
acquired data, making it available for cumulative measure-
ments. In this study, we document the results obtained with
its use in a consecutive series of 972 patients undergoing
diagnostic and interventional coronary procedures at Mayo
Clinic.
METHODS
Patient selection. A consecutive series of 972 patients
undergoing 992 diagnostic and interventional cardiac pro-
cedures was studied during an eight week period in 1997.
These procedures represent all patients who underwent
procedures in five adult cardiac catheterization suites but do
not include an additional 76 procedures which were per-
formed in one of the rooms over a two week period. These
76 procedures were not captured from the single laboratory
due to an equipment malfunction but were representative of
the overall mix in the total sample. Table 1 lists the number
of procedures in several major categories along with patient
characteristics within those categories.
Data were recorded from 706 diagnostic cases where no
coronary intervention was performed. The analysis of diag-
nostic procedures was performed on the majority of these
procedures, after exclusion of: right heart catheterization
procedures (independent of coronary angiography), stand-
alone endomyocardial biopsies and valvuloplasties, intra-
coronary ultrasound studies, and Doppler coronary flow
measurements. This resulted in a total of 597 diagnostic
procedures in which coronary angiography was performed;
in 207 of these, selective coronary angiography was per-
formed without ventriculography while, in another 233
cases, left ventriculography was also performed. The re-
maining diagnostic procedures included, in combination
with coronary angiography: visualization of coronary artery
bypass grafts (aorto-saphenous veins and mammary arteries)
2 81; right heart catheterization 2 56; miscellaneous
procedures such as biopsy and aortography 2 20.
Coronary interventional procedures were performed dur-
ing a total of 286 examinations: 84 as a “stand alone”
procedure while 202 were combined with a diagnostic
coronary angiogram. Two hundred eighty four of the
procedures included coronary angioplasty (PTCA). There
were 235 stent procedures, 17 rotational atherectomy, 1
laser and 2 directional atherectomy procedures. The types of
interventions were not mutually exclusive and the majority
of procedures involved combined interventions.
X-ray equipment. The Mayo Clinic Cardiac Catheteriza-
tion Laboratory currently includes six procedure rooms
which can be used for adult cardiac angiography, each of
which contains a General Electric MPX-100/LUC biplane
x-ray acquisition system (General Electric Medical Systems,
Waukesha, Wisconsin) with a C arm on each plane. One of
the procedure rooms is primarily used for pediatric patients
and occasionally for adult procedures—exposure records
from this room were not included in the analyzed data set.
All imaging chains are identical and include a triple mode
Abbreviations and Acronyms
AP 5 anterior-posterior
AEP 5 area exposure product
C 5 coulomb (also mC-milliCoulomb, nC-
nanoCoulomb, mC/kg, mC/kg/min)
DAP 5 dose area product
ESE 5 entrance skin exposure
Gy 5 gray
HLC 5 high level control
I.I. 5 image intensifier
LAO 5 left anterior oblique
mA 5 milliAmpere
kVp 5 peak kilo Volts
R 5 Roentgen (also R/min and mR-microRoentgen)
PTCA 5 percutaneous transluminal coronary
angioplasty
RAO 5 right anterior oblique
TLD 5 thermoluminescent detector
Table 1. Distribution of Procedures and Patient Characteristics
All
Procedures
Coronary
Angiography
No Intervention
Intervention
Without
Coronary
Angiography
Intervention
With Coronary
Angiography
Number 992 597 84 202
Age 64.6 yr 66.2 yr 65.4 yr 63.6 yr
Male 638 (64.3%) 370 (61.9%) 62 (73.8%) 139 (68.8%)
Weight 82.7 kg 83.2 kg 84.1 kg 81.4 kg
Height 170.4 cm 170.2 cm 171.2 cm 170.1 cm
Chest Thickness 23.0 cm 23.0 cm 23.5 cm 23.0 cm
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image intensifier (11/15/23 cm modes). Entrance exposures
at the image intensifier (I.I.) in all rooms are monitored
routinely and set for the 23 cm I.I. mode to values of 0.34
nC/kg/frame (1.3 mR/frame) for fluoroscopy and 3.9 nC/
kg/frame (15 mR/frame) during cineangiography; corre-
sponding entrance exposures for the 15 cm I.I. mode
typically employed during coronary angiography are 0.62
nC/kg/frame (2.4 mR/frame) and 7.7 nC/kg/frame (30
mR/frame) for fluoroscopy and cine, respectively. The total
filtration for each x-ray tube is adjusted at installation to an
equivalent of 3.5 mm A1 at 80 kVp. The x-ray system
employs pulsed progressive scanning of the video camera
during fluoroscopy (22) and cineangiography—all imaging
is performed at 30 frames/s. All rooms have parallel cine
film and digital acquisition capability as well as operating
modes where the system is operated in digital-only acqui-
sition or “digital cine.” Entrance exposure rates during the
parallel modes are equivalent to the standard cine exposure
rate; during digital cine acquisition, the exposure rate ranges
from cine-equivalent down to one-fourth of the cine rate.
On these systems, the digital cine options are used—at
one-fourth of the cine exposure—in a manner similar to
high level control (HLC) fluoroscopy, when increased
contrast and lower noise relative to standard fluoroscopy are
required, e.g., during attempts to visualize intracoronary
stents of low radio-opacity.
Radiation monitoring system. Radiation measurements
are performed in our laboratory using a Patient Exposure
Monitoring Network (PEMNET) System (Clinical Micro-
systems, Inc, Arlington, Virginia). During each x-ray expo-
sure, the PEMNET system calculates and displays the
real-time exposure rate in R/min based upon the peak kilo
Volts (kVp), milliAmpere (mA), exposure pulse width, and
the geometry of the table and positioners. This provides a
measurement of exposure rate both during fluoroscopy and
cine/digital acquisitions reflecting changes in patient tissue
thickness, projection angles, table height, etc. It should be
noted that, for the purposes of the exposure measurements,
“digital cine” is recorded as a “cine” exposure because the
acquistions are controlled by the cine control circuits of the
x-ray generator. The total cumulative exposure to the
patient is displayed following the end of any single exposure
sequence. Data acquisition modules are interfaced to every
x-ray acquisition plane; at the conclusion of a procedure, the
data are transferred from each procedure room to a standard
personal computer from which data are available for export
and analysis.
The PEMNET system is routinely monitored and cali-
brated to ensure that the patient Entrance Skin Exposure
(ESE) calculated from the acquisition parameters are within a
predetermined tolerance with direct measurements acquired
with an ionization chamber (Radcal Corp., Monrovia, Cali-
fornia). The calibration is performed under conditions which
include the effects of back-scattered radiation. Another set of
measurements is also made with the table and pad placed
between the dosimeter ion chamber and the x-ray source. The
attenuation characteristics of the table and pad at different
energies are determined using these two sets of calibration
measurements and these are compensated for during patient
exposure measurements. The PEMNET software uses statis-
tical analysis of the calibration data to determine the equations
to use in calculating the patient ESE. Quality assurance
procedures in our laboratory include monthly monitoring of
the agreement between PEMNET and ionization chamber
measurements; discrepancies greater than 15% result in a
recalibration of the measurement system.
Phantom measurements. In addition to the routine cali-
bration procedures, exposure measurements were performed
using phantoms to simulate the range of patient thickness
and projection angles representative of clinical routine in our
laboratory. A quality control phantom consisting of 20 cm
of lucite and 4 mm of aluminum was used in combination
with up to 12.5 cm of lucite to simulate a range of patient
thicknesses. This served as a validation of the PEMNET
calculations with phantom thickness and reflects the relative
increase in the x-ray factors one would find during clinical
procedures with patients of different size. In this set of
measurements, the phantom thickness was varied for a fixed
projection angle—straight AP—and a calibrated ionization
chamber measured exposure rates at the entrance plane to
the phantom. The range of thicknesses simulated patient
thickness of approximately 20 to 30 cm. In a second set of
measurements, an anthropomorphic chest phantom was
used to demonstrate the increase in radiation exposure
which would result from typically employed angulation and
correspondingly longer path lengths through patients. This
phantom, consisting of tissue and bone within a housing
which resembles a human torso, provides attenuation of
x-rays similar to what one might expect in an average
patient. Using this phantom, the PEMNET measurements
were recorded as the projection angle was varied.
Statistics. Numerical data are presented as median with
interquartile range unless otherwise stated. Comparisons of
continuous data were performed using the Student’s t-test.
A p value ,0.05 was considered to be significant.
RESULTS
Phantom measurements. The results of the PEMNET
comparison with dosimeter measurements are reported in
Table 2 where the exposure rates during fluoroscopy and
cineangiography are shown for a range of phantom thick-
nesses. The average deviation between the two measure-
ments is 25.4% for the fluoroscopic rates and 24.9% for
cine rates. It should also be noted that, in the straight
antero-posterior (AP) projection, where the effect of pro-
jection angle on the effective patient thickness is minimized,
the exposure rates for our mean patient thickness of 23 cm
were 1.82 mC/kg/min (7.07 R/min) and 21.39 mC/kg/min
(82.9 R/min) for fluoroscopy and cineangiography, respec-
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tively. The effect of projection angle is illustrated in Table 3
where the fluoroscopy and cine exposure rate measurements
are shown as a function of the projection angle. As is evident
from these results, the left anterior oblique (LAO) Cranial
projection requires exposure rates over five times those
which are sufficient in the standard right anterior oblique
(RAO) projection.
Patient results. Radiation exposure measurements along
with measurements of the fluoroscopic and cineangio-
graphic time components are listed in Tables 4 and 5.
Fluoroscopy comprised 89% of imaging time during diag-
nostic cases and 94% during interventional cases. Fluoro-
scopic imaging duration was markedly longer during inter-
ventional cases relative to diagnostic cases (median of 21.0
versus 4.7 minutes, respectively) and the variability was wide
as reflected by an interquartile range of 13.7 to 31.3 min for
all interventional cases combined into a single group.
Cineangiographic acquisition times were relatively short for
all procedures compared with the fluoroscopy time. A
breakdown for several subgroups of interventional proce-
dures is shown in Table 5. The only significant difference
among the measurements was for the cine time measure-
ments for stent and nonstent procedures.
One of the determinants of radiation dose received
during cardiac angiographic procedures is the size of the
patient. A frequency histogram of the study population’s
weight is shown in Figure 1. For the purpose of analysis,
patients were divided into two groups based on their
weight relative to the overall mean weight (,83 kg and
$83 kg) and average exposure rate calculated for fluo-
roscopy and cineangiography from all procedures. Results
are shown in Figure 2. Patients weighing more than
83 kg were exposed to significantly more radiation per
unit time during fluoroscopy than those less than 83 kg:
2.3 versus 1.5 mC/kg/min (8.8 vs. 5.8 Roentgen (R)/
min), p , 0.001. Similarly the exposure per unit time
during cineangiography was greater for heavier patients
than for lighter patients: 44.9 mC/kg/min vs. 27.9
mC/kg/min (173.9 vs. 108.3 R/min). The relative dura-
tions of fluoroscopy and cineangiography did not differ
significantly among patients of different size. For exam-
ple, the median value for fluoroscopy time per case was
7.5 and 7.7 minutes for patients ,83 kg and $83 kg,
respectively. The median cine exposure time was 0.8
minutes for both groups. Alternatively, the patients were
grouped by chest thickness— chest thickness #23 cm and
.23 cm: the results for fluoro rates are 1.5 mC/kg/min
vs. 2.2 mC/kg/min (6.0 vs. 8.7 R/min); for cine rates—
28.6 mC/kg/min versus 44.6 mC/kg/min (110.7 vs.
172.7 R/min). All differences were significant (p ,
0.001) except for the differences in the fluoro time and
cine time measurements. A further breakdown of the
measurements by both chest thickness and procedure
type— diagnostic versus intervention—is shown in Table
6. Here, it can be seen that the major differences in
exposure rates occur as a function of patient size; for all
rate measurements within a type of procedure, the
differences between thin and thick patients were signifi-
cant. The effect of procedure type on exposure rates for
the same patient size group was significant except for cine
rate for thin patients (p 5 0.38 between diagnostic and
interventional procedures). The differences in cine time
Table 2. Phantom Exposure Measurements
Phantom Thickness
(Tissue Equivalent)
(cm)
PEMNET
Fluoro Rate
(R/min)
Dosimeter
Fluoro Rate
(R/min)
Relative
Difference
(%)
PEMNET
Cine Exposure
Rate (R/min)
Dosimeter
Cine Exposure
Rate (R/min)
Relative
Difference
(%)
19.5 3.3 3.47 24.9 36.9 38.6 24.4
22.0 5.8 6.08 24.6 61.0 65.0 26.1
23.2 6.6 7.07 26.6 80.0 82.9 23.4
24.5 7.0 7.39 25.3 97.0 102.0 24.9
25.8 7.7 8.15 25.5 110.0 116.0 25.1
27.0 8.4 8.81 24.6 117.0 124.0 25.6
28.2 9.4 10.0 26.0 130.0 137.0 25.1
Mean Difference 25.4% 24.9%
Exposures were made in the 15 cm I.I. mode using varying thicknesses of lucite and aluminum to produce the same degree of x-ray attenuation as is produced by the equivalent
amount of soft tissue indicated in the table.
Table 3. Variation in Exposure Rate With Projection
Angiographic
Projection
Fluoro Rate
(R/min)
Cine Exposure
Rate
(R/min)
AP 3.1 38.8
RAO 30° 1.9 20.3
LAO 40° 2.0 21.6
LAO 40°, Cran 30° 8.0 99.1
LAO 40°, Cran 40° 9.9 123.6
LAO 40°, Caud 20° 2.9 34.1
An anthropomorphic phantom that includes representative components of tissue,
bone, and air was used to simulate the attenuation from an average-sized patient. The
heart was maintained in the center of the field-of-view as the gantry was rotated to
common angiographic projections. The 15 cm I.I. mode was used for all acquisitions.
AP 5 anteroposterior; RAO 5 right anterior oblique; LAO 5 left anterior
oblique.
430 Cusma et al. JACC Vol. 33, No. 2, 1999
Real-time Exposure Measurement During Angiography February 1999:427–35
for all pairings and for fluoroscopy time across procedure
types were significant but there was no significant differ-
ence in fluoroscopy time within the same type of proce-
dure. The total measured exposure is also significantly
different when comparisons are made across both proce-
dure type and patient size.
DISCUSSION
Comparison with previous studies. Relatively high values
of radiation exposure have been considered a necessary
consequence of cardiac angiographic procedures. With in-
creasing complexity of the procedures, there has been
growing concern regarding the magnitude of the exposure
to operators and patients (1,12,13,17,23). In prior studies, a
complete assessment has been hampered by the fact that
little direct data available on the magnitude of the range of
exposures in currently accepted angiographic procedures.
Early studies that investigated radiation exposure during
cardiac angiography in relatively large numbers of patients were
limited to approximating the value of the x-ray exposure using
indirect measures, namely, the fluoroscopic times during the
procedure and the number of cineframes that were recorded for
the procedure. These approaches do not take into account
variations in patient size, position of the patient relative to the
x-ray tube and detector and the angulation of the X-ray image
intensifier relative to the patient. As demonstrated in the
phantom measurements reported in this study, such variation
can increase exposure rates by as much as a factor of ten
compared to the exposure rate delivered to a relatively thin
patient in the AP projection.
The results presented here are significantly higher than
those from previous studies that have investigated large
numbers of procedures retrospectively. Without dividing
procedures into diagnostic and interventional procedures,
Johnson et al. (1) reported that, from a survey of catheter-
ization laboratories, a typical exposure to the patient of 15.5
to 20.6 mC/kg (60 to 80 R) could be expected. In the report
by Pattee et al. (12), an average skin ESE of 32.0 mC/kg
Table 4. PEMNET Exposure Results—General Grouping
All
Procedures
Coronary
Angiography
No Intervention
Intervention
Without
Coronary
Angiography
Intervention With
Coronary
Angiography
Number 992 597 84 202
Fluoroscopy time 7.2 min 4.5 min 24.6 min 19.0 min
(3.4, 16.5) (2.9, 8.2) (17.5, 37.9) (12.6, 29.2)
Cine time 0.7 min 0.7 min 1.2 min 1.4 min
(0.5, 1.2) (0.5, 0.9) (0.8, 1.8) (1.1, 1.9)
Fluoroscopy exposure 41.3 R 28.9 R 223.5 R 168.4 R
(19.8, 120.3) (17.0, 50.7) (166.1, 364.3) (94.5, 256.7)
Cine exposure 104.4 R 94.8 R 149.5 R 185.8 R
(59.3, 162.4) (59.4, 133.6) (94.8, 220.8) (117.7, 262.6)
Total exposure 162.1 R 135.3 R 388.9 R 358.4 R
(94.3, 287.2) (89.1, 191.3) (275.3, 589.9) (236.7, 527.2)
Results are presented as median and interquartile intervals. All differences among procedure subgroups were significant (p , .01) except the difference in total exposure between
the intervention with coronary angiography and intervention without coronary angiography groups (p 5 0.17).
Table 5. PEMNET Exposure Results—Interventional Subgroups
Any PTCA
PTCA
Without Stent Any Stent
Number 284 51 235
Fluoroscopy time 21.0 min 17.9 min 21.9 min
(13.7, 31.3) (10.2, 25.9) (14.4, 33.2)
Cine time 1.4 min 1.1 min 1.4 min
(1.0, 1.9) (0.8, 1.4) (1.1, 2.0)
Fluoroscopy exposure 188.4 R 189.6 R 188.0 R
(110.6, 280.3) (94.0, 243.5) (115.2, 287.3)
Cine exposure 173.7 R 166.6 R 174.4 R
(111.3, 252.8) (110.2, 249.1) (113.2, 252.8)
Total exposure 370.5 R 362.3 R 376.0 R
(241.8, 543.9) (257.8, 469.3) (239.2, 555.6)
Results are presented as median and interquartile intervals. The difference in the cine time between the PTCA Without Stent
and both other subgroups was significant at p , 0.001; no other differences were significant.
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(124 R) for a typical angioplasty procedure was calculated
for over 1800 PTCA procedures. The calculations in their
study assumed a value for fluoroscopic and cine exposure
rate which is often exceeded with steep angulations and
thicker patients. As shown in our data, their values of 0.52
mC/kg/min (2.0 R/min) during fluoroscopy and 13.9 mC/
Figure 1. Distribution of patient size over the procedures used for measurement of patient radiation exposure during angiographic
procedures.
Figure 2. The results of procedure radiation exposure measurements grouped by patient size. Results are presented as median and
interquartile intervals. Differences between the subgroups for Exposure measurements were significant (p , 0.001).
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kg/min (54 R/min) during cine are characteristic of an
average patient in the RAO view but the rates go up
significantly with steeper LAO angulations. A survey of
practice in the U.K. reported by Coulden et al. (11) resulted
in patient exposure estimates from 5.2–16.8 mC/kg (20–
65 R) but no corrections were made for varying projections
and their effect on effective patient thickness, nor was there
any differentiation made between diagnostic and interven-
tional procedures. The patient exposure estimates for all but
five of the 36 responding sites were also made using
fluoroscopy time and length of cine film. Huyskens et al.
(10) applied representative “kerma-exposure product” mea-
surements from a small number of procedures to two years
worth of procedures in a single large laboratory in the
Netherlands. The actual calculations were derived from fluo-
roscopy time and cine film length for over 3000 procedures. A
previous report from our laboratory (21), using an average
estimation approach from fluoroscopy and cineangiographic
times, calculated patient exposures for interventional proce-
dures ranging from 12.9–30.9 mC/kg (50– 120 R). There was
no correction made for varying projection angles; the authors
emphasized that such measurements should be considered the
minimum expected exposure.
There have been previous direct measurements or calcu-
lations of exposure to operators and patients on a case-by-
case basis. Dash et al. (9) reported one of the first investi-
gations of the variation with PTCA using film badges and
TLD’s to measure cumulative exposure to operators during
a total of 58 angiographic procedures. Although they did
not measure exposure to the patient, they did find that
angioplasty resulted in 93% greater exposure to the operator
than did diagnostic procedures. No quantitative measure-
ments were made but the authors did note the increased use
of cranial angulation under fluoroscopy during angioplasty
compared with routine angiography. Cascade et al. (18)
used TLD measurements in approximately 110 patients to
compare PTCA to coronary angiography. Their technique
was designed to take into account the effect of projection
angle and they found that angioplasty procedures produced
nearly four times as much exposure to patients as did
angiography—17.8 versus 5.2 mC/kg (69 vs. 20 R). They
also found a factor of two increase in exposure for proce-
dures where two interventions were performed compared to
one. A dosimetric study on 58 procedures by Zorzetto et al.
(13) looked at dose to operators using TLD’s and to the
patient using a meter indicating dose-area-product (DAP).
They found that the DAP was about 70% higher for PTCA
than for diagnostic angiography. The results of the DAP
measurements were mean values of 55.9 and 91.8 Gy-cm2
for diagnostic and interventional procedures, respectively. A
recent study by Bakalyar et al. (17) collected Area-
Exposure-Product (AEP) data for 510 consecutive proce-
dures, resulting in AEPs of 144.0–227.0 Gy-cm2 (16,500–
26,000 R-cm2) for interventional procedures of various
types compared with 94.3 Gy-cm2 (10,800 R-cm2) for
diagnostic procedures. Assuming an entrance area of
100 cm2, this corresponds to a range of 42.6–67.0 mC/kg
(165–260 R) and 27.9 mC/kg (108 R), respectively. They
also differentiated among different types of interventions as
well with, for example, stent procedures being 60% higher
exposure than PTCA alone.
Advantages of real-time exposure measurement. Among
the questions prompted by the results in this study is
whether they may be attributable to unique aspects of our
laboratory or the type of procedures performed or whether,
instead, they are representative of general changes in angio-
graphic practice over time. A major difference in the
methodology of this study is that the exposure to the patient
is calculated in real-time and reflects all factors which affect
the radiation exposure during an angiographic procedure.
As such, these results cannot be directly compared with
other experiences because other reported methods do not
measure parameters under these conditions. The increase in
Table 6. PEMNET Exposure Results—Grouped by Patient Chest Dimension for Interventional and Diagnostic Procedures
Any
Intervention
Chest < 23 cm
Any
Intervention
Chest > 23 cm
Diagnostic
Chest < 23 cm
Diagnostic
Chest > 23 cm
Number 158 120 331 258
Fluoroscopy Time 21.9 min 21.1 min 4.3 min 5.0 min
(14.6, 30.9) (13.4, 31.7) (2.9, 7.6) (2.9, 8.7)
Fluoroscopy Exposure Rate 7.9 R/min 9.8 R/min 5.1 R/min 8.0 R/min
(6.3, 9.1) (8.5, 11.4) (3.7, 6.8) (6.3, 10.1)
Cine Time 1.5 min 1.3 min 0.7 min 0.7 min
(1.1, 2.0) (0.9, 1.7) (0.5, 0.8) (0.6, 0.9)
Cine Exposure Rate 108.8 R/min 157.4 R/min 112.5 R/min 180.9 R/min
(79.4, 137.8) (123.9, 206.4) (81.4, 143.3) (140.4, 216.6)
Total Exposure 328.7 R 432.2 R 106.0 R 174.1 R
(219.8, 484.1) (292.4, 635.2) (71.5, 150.0) (133.9, 235.7)
Results are presented as median and interquartile intervals. All differences between measurements across procedure type (for a given patient size) and within a procedure type
(for different patient size) were statistically significant except for fluoroscopy time within procedure type and cine exposure rate between procedure type for thinner patients. The
difference in cine time between thin and thick patients in diagnostic procedures was significant at p 5 0.012 and in interventional procedures at p 5 0.03.
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exposure with patient size, for example, is demonstrated by
the phantom simulation in this study and agrees with results
reported by Boone et al. (24) who looked at changes in
scatter radiation to personnel as patient thickness increases.
Similar issues with respect to the effects on exposure to the
operator of modifying views during coronary angioplasty
were addressed by Pitney et al. (25). From these results, one
can see that moving from straight AP to shallow RAO to
steep LAO cranial angulation can increase the exposure by
a factor of three or more. The results in our study are also
consistent with computer simulations and measurements by
Stern et al. (26).
Another factor that cannot be accounted for in “average”
approaches is the increasing use of “high level control”
(HLC) fluoroscopy as a result of an increase in the propor-
tion of interventional procedures that require the deploy-
ment of stents in the coronary arteries. Recognized as a
contributor to higher radiation exposure with the advent of
PTCA (27), HLC fluoroscopy can result in exposure rates
as high as that of cineangiography—on the order of ten
times normal fluoro—and, when used during positioning of
stents and balloons, can lead to significantly greater expo-
sure times than during cine. Although the digital cine mode
used in our laboratory is not strictly an HLC fluoroscopy
mode, it is utilized in a similar manner during interventional
procedures and is representative of practice in a number of
laboratories. The longer total cine exposure times for
interventional procedures reported in our data can most
likely be attributed to the contribution from the digital cine
mode of acquisition. Other laboratories’ use of HLC may be
logged as fluoroscopic exposure despite the fact that the
exposure rate may in fact be closer to that of cine acquisi-
tion. The significant difference in our data for cine time
measurement between stent and nonstent procedures would
support this hypothesis.
Potential for radiation-induced skin injury in coronary
angiography. Another question that needs to be addressed
is whether, considering the magnitude of the total proce-
dure exposures, one should expect to report a high frequency
of skin effects. There have been no such reports in our
catheterization laboratory and this can most likely be attrib-
uted to the fact that the totals reported in this study are, in
fact, integrated over all projection angles and do not
represent the total exposure to any single area of skin. As
illustrated in the comprehensive analysis by Stern et al. (26),
the distribution of x-ray exposure during a typical catheter-
ization procedure varies greatly over the range of typical
views. If, instead, all of the radiation had been delivered over
the same area of skin, exposures at the higher end of the
values reported in our measurements—77.4 mC/kg (300 R)
and greater—might be considered at the threshold of such
effects.
Recommendations. There is some uncertainty in the lit-
erature related to the appropriate degree of concern regard-
ing the amount of x-ray exposure to the patient
(6,11,12,17). Although all agree that the highest quality
diagnostic images are the primary consideration during
angiography, any precautions that can reduce unnecessary
exposure should be taken as well. Careful monitoring of the
performance of equipment— especially x-ray and I.I.
tubes—should be performed to detect increases in the
amount of x-rays required to form an adequate image.
Reduction of exposure can be achieved through the use of
reduced frame rate fluoroscopy and cineangiography; the
increasing use of digital angiography without cinefilm re-
cording should make the latter more feasible, and attention
should be paid to patient and I.I. position. The use of HLC
fluoroscopy should be considered only when necessary and,
if available, the frame rate should be no higher than
necessary: 15 frames/s results in a straightforward reduction
in exposure by a factor of two.
Conclusions. Patient x-ray radiation exposures during car-
diac catheterization procedures have increased as a result of
the increased complexity of the angiographic procedures
performed in current clinical practice. The increasing prev-
alence of coronary artery stent deployment has led to
significant increases in the exposure to patients during
fluoroscopic and cineangiographic imaging. Monitoring of
x-ray exposure in the catheterization laboratory is facilitated
through the use of real-time exposure measurements that
display and record exposure as parameters are changed
continuously during a procedure.
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